Last reviewed · How we verify
NCT07065734: NEWER
NEgative prEssure Wound Therapy in Renal Transplant
Phase 4 trial testing NWPT group in Transplant Complication in 150 participants. Currently enrolling.
31 May 2026
Quick facts
| Lead sponsor | Centro Hospitalar De São João, E.P.E. |
|---|---|
| Phase | Phase 4 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 150 |
| Start date | 1 January 2023 |
| Primary completion | 31 May 2026 |
| Estimated completion | 30 June 2026 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- NWPT group
Conditions studied
- Transplant Complication — all drugs for Transplant Complication →
- Renal Transplant — all drugs for Renal Transplant →
- Wound Complication — all drugs for Wound Complication →
Sponsor
Centro Hospitalar De São João, E.P.E.
Who can join
18 and older, any sex, with Transplant Complication or Renal Transplant. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective study involving patients undergoing open renal transplant. Renal transplant recipients were randomly divided into two groups: the NPWT group, which received NPWT, and the Standard group, which received standard wound dressings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07065734
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Transplant Complication
Currently open trials in the same condition.
- NCT07349498 — Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation · recruiting
- NCT06186843 — Plant-based Diet for Kidney Transplant Recipients · NA · active not recruiting
- NCT06063213 — Using Transcriptional Assessment of Immune Response to Assess Immunosuppression After Liver Transplantation · active not recruiting
- NCT05762211 — Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial) · Phase 2 · recruiting
- NCT06493812 — Comparison of Clinical Value in the Use of the Fascia Lata and Temporal Muscle Fascia in the Reconstruction of the Dura · NA · recruiting
Other Centro Hospitalar De São João, E.P.E. trials
Trials by the same sponsor.
- NCT06015373 — The Impact of Carvedilol Posology on Clinically Significant Portal Hypertension · NA · completed
- NCT07411326 — Does Intraoperative Application of Steroids Affect Early Outcomes in Patients Undergoing Endoscopic Lumbar Discectomy? · NA · completed
- NCT05114395 — Comparison Between a Telerehabilitation Program for Urinary Incontinence Versus a Conventional Face-to-face Program · NA · completed
- NCT05321680 — Withdrawal of Antidementia Drugs in Advanced Dementia (WADAD) · NA · completed
- NCT05360199 — Are Postoperative Patient PROMS Influenced by Recall of Preoperative Scores? · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07065734 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centro Hospitalar De São João, E.P.E.
- Last refreshed: 15 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07065734.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing